GleamWall
中文EN

RPID RAPID MICRO BIOSYSTEMS, INC.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1380106 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY16.1%
TTM net income YoY-16.1%
TTM EPS YoY-11.0%
Revenue 3-yr CAGR22.5%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-141.5%
Net margin-145.6%
FCF margin-114.8%
EBITDA margin-133.0%

Returns

ROE-141.6%
ROA-76.4%
ROIC (approx.)-135.2%
Asset turnover0.52x

Leverage & solvency

Liabilities / assets69.6%
Debt / equity1.08x
Current ratio2.55x
Interest coverage-21.16x

Cash quality & payout

Operating cash flow / net income0.78x
Accruals ratio-16.6%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
Income statement
Revenue$8.05M$8.00M$11.28M$7.84M$7.26M$7.21M$8.22M$7.60M
Cost of revenue$6.84M$7.63M——$6.99M$6.80M——
Gross profit$1.21M$371,000——$275,000$404,000——
R&D expense$3.33M$3.36M$3.22M$3.53M$3.23M$3.62M$3.40M$3.61M
SG&A expense$6.77M$7.44M$5.34M$5.64M$6.08M$5.69M$4.83M$5.68M
Operating income-$12.32M-$13.85M-$12.21M-$11.37M-$12.15M-$11.66M-$10.23M-$12.04M
Interest expense$646,000$639,000$673,000$393,000$12,000$12,000$12,000$11,000
Income tax$45,000$8,000$14,000$8,000$11,000$7,000-$9,000$13,000
Net income-$12.92M-$14.28M-$12.50M-$11.51M-$11.86M-$11.26M-$9.67M-$11.32M
EBITDA-$11.65M-$13.15M-$11.42M-$10.57M-$11.34M-$10.81M-$9.36M-$11.18M
EPS (basic)-0.27-0.31—-0.26-0.27-0.26—-0.26
EPS (diluted)-0.27-0.31—-0.26-0.27-0.26—-0.26
Weighted avg. shares (diluted)48.35M45.43M—44.96M44.65M43.99M—43.67M
Balance sheet
Cash & equivalents$14.69M$13.81M$20.03M$18.95M$18.62M$19.27M$17.28M$22.33M
Short-term investments$5.08M$9.13M$18.27M$22.30M$12.92M$22.76M$33.82M$38.79M
Receivables$5.51M$6.37M$3.13M$5.43M$6.05M$4.52M$7.52M$3.74M
Inventory$18.92M$17.45M$17.59M$21.07M$20.56M$20.72M$20.20M$21.25M
Current assets$46.26M$49.23M$61.17M$69.95M$60.15M$69.18M$80.92M$87.93M
PP&E, net$8.16M$8.77M$8.97M$9.58M$10.21M$10.56M$11.19M$11.56M
Total assets$58.45M$62.36M$74.85M$84.41M$75.59M$85.43M$98.17M$105.84M
Current liabilities$18.15M$19.12M$18.49M$16.55M$16.40M$15.00M$17.57M$15.92M
Long-term debt$19.14M$19.05M$18.90M$18.83M——$0—
Total debt$19.14M$19.05M$18.90M$18.83M——$0—
Total liabilities$40.70M$41.97M$41.65M$40.08M$21.04M$19.94M$22.82M$21.47M
Shareholders' equity$17.75M$20.40M$33.21M$44.33M$54.55M$65.49M$75.35M$84.37M
Net debt$4.45M$5.24M-$1.13M-$118,000——-$17.28M—
Cash flow statement
Operating cash flow-$12.70M-$15.06M-$3.25M-$9.05M-$9.70M-$9.06M-$9.91M-$8.60M
Capital expenditure-$223,000$394,000$92,000$73,000$366,000$319,000$98,000$223,000
Free cash flow-$12.48M-$15.45M-$3.34M-$9.12M-$10.07M-$9.38M-$10.01M-$8.82M
Investing cash flow$4.22M$8.60M$3.89M-$9.58M$9.34M$10.68M$4.86M-$6.54M
Financing cash flow$9.35M$247,000$443,000$19.25M-$298,000$379,000-$6,000$61,000
Depreciation & amortization$674,000$706,000$790,000$804,000$811,000$847,000$869,000$859,000
Stock-based compensation$1.32M$1.22M$627,000$1.15M$1.22M$1.04M$689,000$929,000

Free plan shows the latest 8 periods; Pro shows all 26 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.